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Objective: The pathophysiology of anterior cruciate ligament (ACL) rupture leading to knee osteoarthritis
(OA) remains largely unknown. It seems that bone loss occurs after ACL rupture. The purpose of our study
was to determine bone mineral density (BMD) changes in the knee after ACL rupture during 2-year
follow-up period and to compare BMD changes between the injured and healthy contralateral knee.
Design: Patients were included in an observational prospective follow-up study within 6 months after
ACL trauma and evaluated for 2 years. Patients were treated operatively or non-operatively. At baseline
and at the one- and 2-year follow-ups, BMD was measured in six regions of the tibia and femur for both
knees (medial, central, lateral) using a Dual-energy X-ray Absorptiometry (DXA) scanner.
Results: One hundred forty-one patients were included, with the following characteristics: 66% were
male, median age at baseline was 25.3 (inter-quartile range 11.3) years, and 63% were treated operatively.
After 1 year, BMD was signiﬁcantly lower in all regions of the injured knee of the operatively treated
patients compared to baseline. After 2 years, BMD was signiﬁcantly increased, but remained lower than
the baseline levels. In all regions for all measurements, the mean BMD was signiﬁcantly lower in the
injured knee than in the healthy contralateral knee.
Conclusions: During a 2-year follow-up period after ACL rupture, the BMD level in the injured knee was
found to be lower than in the healthy contralateral knee. In operatively treated patients, the BMD
decreased in the ﬁrst year and increased in the second follow-up year.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Anterior cruciate ligament (ACL) rupture is a common sports-
related injury, with an annual incidence of approximately ﬁve per
10,000 persons in the general population1. Frobell et al. and a
population based study of cruciate injuries in Sweden showed a
higher incidence of approximately eight per 10,000 persons2,3.
Osteoarthritis (OA) is a well-known long-term consequence of ACL
rupture. A systematic review showed that highest rated studies
regarding methodology, reported prevalences of 10e13% of knee
OA 10 years after isolated ACL injury and they found prevalences of
21e48% for combined ACL injuries4. Better understanding of the: B.L. van Meer, Department
Medical Center Rotterdam,
lands. Tel: 31-10-7036106;
n Meer).
s Research Society International. Ppathophysiology of ACL rupture leading to OA may aid in pre-
venting the onset or progression of OA and speed the development
of disease-modifying OA drugs.
Previous studies suggest that changes in bone play a role in the
development and progression of OA5e7. Bone metabolism increases
in OA joints. Dieppe et al.8 showed that, in patients with knee OA, a
positive bone scintigraphy predicted loss of joint space. These
ﬁndings suggest that the OA process is active in both cartilage and
bone. Furthermore, biomarkers of cancellous bone collagen meta-
bolism were found in high concentrations in osteoarthritic hips,
suggesting increased bone turnover in the OA process9. Several
animal studies showed a decrease in subchondral bone thickness
after induction of OA, indicating that this is an early event in the OA
process10e13. Hayami et al. observed subchondral bone loss soon
after surgery in an OA-induced rat model, followed by an increase
of the subchondral bone volume, resulting in subchondral bone
sclerosis14. In early human OA, Bolbos et al. reported a reduction in
bone volume, supporting the ﬁndings of the animal studies15.
Clinical studies showed that degenerative changes were associatedublished by Elsevier Ltd. All rights reserved.
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studies had existing radiological and clinical OA. These ﬁndings
suggest a biphasic process of BMD changes in OA: a reduction in
BMD early on followed by an increase during more advanced
phases.
To understand how post-traumatic OA develops, we are inter-
ested in the effect of ACL rupture on BMD early in the OA process.
Indeed, other investigators have suggested that bone loss occurs in
the aftermath of ACL rupture19,20. Ten studies investigating the
inﬂuence of ACL injury and reconstruction on BMD of the involved
lower extremity were included in a recent systematic review by
Nyland et al.19. All 10 studies reported that BMD or bone content did
not return to normal levels after ACL injury or reconstruction.
However, the studies measured BMD levels at different locations:
patella, distal femur, proximal tibia, several hip sites, lumbar spine
and calcaneus. Therefore, comparison of the studies is difﬁcult.
Another limitation is that the subgroup of studies that examined
BMD in regions outside the knee evaluated only an indirect effect of
ACL trauma on BMD, in terms of unloading. To evaluate both direct
(inﬂuence on the knee joint) and indirect effects on BMD, mea-
surements in the distal femur and proximal tibia are necessary.
Moreover, most of the included studies had small sample sizes:
nine of the 10 studies included fewer than 50 patients. The range of
time between ACL injury or reconstruction and BMDmeasurement
varied between 4 months and 11 years. Due to this variation in
follow-up time, it is difﬁcult to distinguish between short- and
long-term effects on BMD. Furthermore, identiﬁcation of BMD
changes over timewas not possible becausemost of the studies had
only one BMD measurement. A recent randomized controlled trial
comparing BMD changes in the knee and hip of three different ACL
reconstruction techniques found transient BMD loss in the knee in
the ﬁrst year post-operative21.
Owing to weaknesses and heterogeneity of the included studies
in the previously mentioned systematic review19 and the contra-
dictory results compared with the randomized controlled trial of
Lui et al.21, we aimed to investigate BMD changes in the knee
following ACL rupture in a large prospective cohort by using stan-
dardized regions of interest (ROIs) in the knee. We used ﬁxed time
points: baseline,1 year and 2 years. The purpose of our study was to
determine BMD changes in the knee after ACL rupture during a
2-year follow-up period and to determine BMD changes between
the injured and contralateral knee. Furthermore, we assessed the
presence of interaction between BMD changes during follow-up
and treatment choice and we assessed the relationship between
activity level and BMD.
Methods
Population
Between January 2009 and November 2010,154 eligible patients
were included in the KNee osteoArthritis anterior cruciate Liga-
ment Lesion (KNALL) study. The patients were recruited from three
hospitals in the Netherlands: Erasmus MC University Medical
Center Rotterdam, Medical Center Haaglanden The Hague, and
Reinier de Graaf Groep Delft. The KNALL study is a prospective
observational study of patients who visited the outpatient clinic
within 6 months after trauma. Inclusion criteria were, age between
18 and 45 years, and presence of ACL rupture diagnosed by physical
examination and magnetic resonance imaging (MRI). Patients who
did not speak the Dutch language; those with previous ACL injury
or meniscus or cartilage damage; those with previous surgery of
the involved knee; those with disabling co-morbidity; and those
already with osteoarthritic changes on X-ray (Kellgren and Law-
rence (K&L) grade >0) were excluded. The contralateral knee ofeach included patient comprised a control group. The included
patients were evaluated at baseline, and after 1 and 2 years. BMD
measurements were made in 141 of 154 of the included patients.
The 13 patients without BMD measurements were not willing to
visit the main research center to have Dual-energy X-ray Absorp-
tiometry (DXA) scans performed. Contralateral knees with radio-
graphic knee OA (K&L score >0) or ACL injury or meniscus or
cartilage injury were excluded. One hundred twenty-two contra-
lateral knees were included in the control group; 19 were excluded
because of intra-articular knee injury (n ¼ 17) or presence of
radiographic OA (n¼ 2) at baseline. One patient was not available at
baseline for DXA scan measurement, but at follow-up he partici-
pated in both DXA scan measurements. Of the ﬁnally 122 contra-
lateral knees of the included patients, 96 were measured at
baseline, 109 at the 1 year follow-up and 108 at 2-year follow-
up (see Fig. 1).
The decision for operative or non-operative treatment was
made by the patient and orthopedic surgeon. In the operatively
treated patients the following ﬁxationmethodswere used. By using
hamstring tendon (HT) grafts or combination of HT and allografts,
on the femoral side the tendon was ﬁxed with an extracortical
button technique (Endobutton; Smith & Nephew) or with a Bio-
TransFix implant (Arthrex) and on the tibial side with a resorb-
able interference screw (Smith & Nephew) or a Delta Tapered Bio-
Interference Screw (Arthrex) was used for the ﬁxation and if the
torque was below 15 N, then a staple (Arthrex) was placed as extra
ﬁxation. By using bone-patella tendon-bone grafts, both sides were
ﬁxed with a resorbable interference screw (BioRCI; Smith &
Nephew).DXA scan measurement
The knee BMD was measured by DXA using a Lunar Prodigy
scanner (GE Lunar Corp., Madison, WI, USA). Because the standard
program of the DXA scanner had no knee protocol, we chose to use
the spine protocol, which ﬁt our purpose best in terms of pre-
deﬁned ﬁeld of view.
The position of the patient was standardized. The lower ex-
tremity was ﬁxed in a plastic device and the knee slightly ﬂexed
(10). The leg was ﬁxed in a 15 internal rotation for positioning the
patella centrally. The positioning laser light was used to position
the center of the scanner arm 8 cm below the tuberositas tibiae.
This resulted in antero-posterior views.
We outlined the contours of the femur and tibia by placing
anatomical landmark points using the freely available active shape
model toolkit software package (Manchester University, Man-
chester, UK). Each landmark point was placed on corresponding
positions on each scan. Using speciﬁc anatomical landmark points,
we automatically extracted six ROIs: medial, central, lateral in the
tibia, and medial, central and lateral in the femur (see Fig. 2 for
regions and used landmark points). The height and placement of
the regions were based on reference lines between landmark points
that indicated the medial and lateral sides of the tibia and femur
(see Fig. 2). In the tibia, the regions run from the lower point of
these lines up to a point 30% beneath the top of the line. This was to
assure that the regions were positioned below the subchondral
bone. In the femur, the bottom of the regions was positioned 10% of
the length of the reference line above the lowest point, while the
top was placed at 50%. The regions in the femur were positioned
such that the medial and lateral ROIs were placed inside the
respective condyles. The most lateral and medial border of the ROIs
in the tibia and femur were positioned parallel to the outline of the
tibia and femur, at a distance from the outline of 5% of the width of
the bone. The area without bone in the central region of the femur,
eFig. 1. Overview of included patients. Abbreviations; KNALL, KNee osteoArthritis anterior cruciate Ligament Lesion; DXA, Dual-energy X-ray Absorptiometry; K&L, Kellgren and
Lawrence score.
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analysis (Fig. 2).
Reproducibility
The testeretest consisted of two aspects. First, the testeretest
for placing landmark points was assessed in 25 scans, which were
randomly chosen, by placing the landmark points twice. The time
between the ﬁrst and second placement of the landmark points
was 1 month. Second, the testeretest for positioning the patients
under the DXA scanner was assessed during the 2-year follow-up in
50 patients by measuring the patients at the beginning and end of
their visit. After the ﬁrst scan the patients got up from the scanner
bed, then we did the other measurements (physical examination
and questionnaires) and at the end of the visit the patient lied down
again on the scanner bed, resulting in repositioning of the patient.
Questionnaire
At all visits the patients were asked to ﬁll in the Tegner activity
score22. At baseline the patients were asked to ﬁll in their activitylevel pre-injury and their activity level at the moment of their
baseline measurements. The Tegner activity score is a knee related
activity scale where work and sport activities are graded. Score 10
represents competitive sports as soccer (national and international
elite) and score zero represents sick leave or disability pension
because of knee problems.Statistical analysis
Statistical analyses were performed with IBM SPSS Statistics
20.0 (SPSS Science Inc., Chicago, USA).
The reproducibility of the DXA scanmeasurements was assessed
by determining the intraclass correlation coefﬁcient (ICC; two-way
random effects model, absolute agreement).
Generalized estimating equation (GEE) analyses were conduct-
ed to analyze if the BMD levels were different depending on the
time of measurement (T0, T1 and T2), side (injured and contralat-
eral knee) and treatment choice (non-operative and operative
treatment). The GEE model takes into account the correlation be-
tween left and right knees within one person and the correlation
between the time points within one person. We adjusted for age,
Fig. 2. Determination of six regions of interest (ROIs by using landmark points. 1:
medial tibia, 2: central tibia, 3: lateral tibia, 4: medial femur, 5: central femur, 6: lateral
femur.
Table I
Patient characteristics. Data are presented as median (inter-quartile range), unless
otherwise indicated *Signiﬁcant difference (P value < 0.05) between non-
operatively and operatively treated groups. Abbreviations: BPTB, bone e patellar
tendon e bone; HT, hamstring tendon
n ¼ 141
Baseline characteristics
Age (years) 25.3 (11.3)
Gender (female) e n (%) 48 (34)
BMI (kg/m2) 23.7 (4.3)
Injured side (right) e n (%) 75 (53)
Time, injury to DXA measurement at baseline (months) 2.6 (2.3)
Treatment variables during follow-up
Treatment e n (%)
-Non-operative 47 (33)
-Operative 90 (64)
-Lost to follow-up 4 (3)
Time, injury to reconstruction (months) 5.7 (5.1)
Graft type e n (%)
-HT 82 (91)
-BPTB 5 (6)
-Combination (HT/allograft) 3 (3)
Activity
Tegner score pre trauma
-All patients 9 (2)
-Non-operative 8 (3)*
-Operative 9 (2)
Tegner score at baseline
-All patients 3 (2)
-Non-operative 3 (2)
-Operative 3 (1)
Tegner score at 1-year follow-up
-All patients 6 (3)
-Non-operative 6 (3)
-Operative 6 (4)
Tegner score at 2-year follow-up
-All patients 7 (4)
-Non-operative 5 (3)*
-Operative 7 (4)
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the residuals of all BMD analyses had a normal distribution.
We used linear regression analyses to explore if the BMD values
at baselinewere associated with the time between trauma and DXA
scan measurement at baseline. We hypothesized that the BMD
values at baseline of the patients can be inﬂuenced by a difference
in pre-trauma activity level. Thereby we hypothesized that the pre-
trauma activity level of operatively treated patients would be
higher than the non-operatively treated patients. We used the
ManneWhitney U test to explore whether the pre-trauma Tegner
activity score differed between the operatively and non-operatively
treated patients.
Signiﬁcance was assumed for a P value <0.05. We took into
account the effects of multiple testing both within ROIs and be-
tween ROIs. Within ROIs we have used the bonferroni adjustment
in the post-hoc analysis of the GEE models. Between ROIs we
adjusted the signiﬁcance threshold to 0.008 (a level/k tests: 0.05/6
ROIs ¼ 0.008).Results
The characteristics of the included patients are presented in
Table I. The time between injury and baseline DXA scan measure-
ment had no inﬂuence on the BMD levels in all ROIs. Consequently,we decided not to correct for the variable time between injury and
baseline visit.
Reproducibility
The ICCs of the BMD levels in the ROIs for placing landmark
points ranged from 0.89 to 1.00. For positioning of the patient
under the DXA scanner, the ICCs of the BMD levels in the ROIs
ranged from 0.85 to 0.96 in the injured knee and from 0.88 to 0.97
in the contralateral knee.
BMD changes during follow-up
The BMD of the injured kneewas signiﬁcantly lower at the 1-year
follow-up in all ROIs, compared to baseline. At the 2-year follow-up,
BMD was signiﬁcantly increased again compared to the 1-year
follow-up, in all ROIs except for the medial tibia (MT). The BMD
levels in the central and lateral tibia (LT) and medial femur (MF)
remained signiﬁcantly lower than at baseline. In the contralateral
knee, BMD changes were much smaller. In the tibia, all regions
showed a slight but signiﬁcant decrease in the ﬁrst follow-up year,
which did not recover by the 2-year follow-up. In contrast, BMD in
the femur did not change or even increased slightly, which was sig-
niﬁcant after1 and2years in thecentral regionof the femur (Table II).
BMD differences between injured and contralateral knees
In all ROIs at all time points the BMD level of the injured knee
was signiﬁcantly lower than the BMD level of the contralateral
knee (Table III).
Table II
Bone mineral density (BMD) levels in injured and contralateral knees. Abbreviations: contralat: contralateral; MT: medial tibia, CT: central tibia, LT: lateral tibia, MF: medial
femur, CF: central femur, LF: lateral femur. BMD is presented in g/cm2. All analyses were adjusted for age at baseline, BMI and gender. In bold, P values <0.05 .BMD is presented
in g/cm2
ROI T0
Injured n ¼ 140
Contralat n ¼ 96
Mean (SD)
T1
Injured n ¼ 130
Contralat n ¼ 109
Mean (SD)
T2
Injured n ¼ 128
Contralat n ¼ 108
Mean (SD)
T0eT1
P value
T1eT2
P value
T0eT2
P value
MT injured 0.95 (0.13) 0.92 (0.13) 0.95 (0.14) <0.001 <0.001 1.000
contralat 0.99 (0.12) 0.98 (0.12) 0.99 (0.12) 0.016 0.086 1.000
CT injured 0.96 (0.15) 0.90 (0.15) 0.92 (0.16) <0.001 0.001 <0.001
contralat 1.01 (0.15) 0.99 (0.15) 0.98 (0.16) 0.001 0.205 <0.001
LT injured 0.96 (0.1422) 0.91 (0.14) 0.94 (0.15) <0.001 <0.001 0.047
contralat 1.01 (0.14) 0.99 (0.14) 0.99 (0.14) <0.001 1.000 0.002
MF injured 1.07 (0.12) 1.00 (0.13) 1.03 (0.13) <0.001 0.718 <0.001
contralat 1.11 (0.12) 1.11 (0.12) 1.10 (0.11) 1.000 1.000 0.539
CF injured 1.36 (0.15) 1.32 (0.15) 1.36 (0.16) <0.001 <0.001 1.000
contralat 1.39 (0.13) 1.41 (0.14) 1.42 (0.13) 0.038 0.559 <0.001
LF injured 1.24 (0.21) 1.19 (0.21) 1.25 (0.22) 0.001 <0.001 1.000
contralat 1.28 (0.19) 1.28 (0.20) 1.30 (0.21) 1.000 0.141 0.309
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Forty-seven patients (33%) were treated non-operatively, 90
patients (64%) operatively, and the treatment given to four patients
was unknown because of the following reasons: lost to follow-up
(n ¼ 2), foreign stay during both follow-up years (n ¼ 1), and not
willing to participate (n ¼ 1). The operatively treated group had
signiﬁcantly higher Tegner activity scores both pre-trauma and at
the 2-year follow-up compared to the non-operatively treated
group (Table I).
The BMD levels of the operatively treated group showed the
same pattern during follow-up as was observed for the whole
group. In the non-operatively treated group, the BMD levels did not
signiﬁcantly change during follow-up, except for the central region
of the tibia. In this region, the BMD level had decreased signiﬁcantly
in the ﬁrst year and decreased even further in the second follow-up
year. At baseline, the operatively treated patients had a higher BMD
than the non-operatively treated patients. After 1 year, all regions
of the tibia and femur had lower BMDs in the operative group than
in the non-operative group, except for the lateral femur (LF). At 2
years’ follow-up, the BMDs in all regions, except the medial and
central region of the femur, were higher again in the operative
group than in the non-operative group. However, all these differ-
ences did not reach signiﬁcance (Table IV).
In the non-operatively treated group, the injured knee had a
signiﬁcantly (P value <0.008) lower BMD level than the contralat-
eral knee at all time points in all ROIs of the tibia and femur, except
for the central and lateral region of the femur. In the operatively
treated group, all ROIs in the tibia of the injured knee had signiﬁ-
cantly (P value <0.008) lower BMDs than the contralateral knee at
all time points. For the femoral regions similar ﬁndings were found.
Only at baseline these differences were not signiﬁcant.Table III
BMD difference between injured and contralateral knee at all time points. Delta BMD is
multiple testing)
T0 T1
ROI Delta BMD (contralateral-
injured) mean (SD)
P value Delta BMD (contr
injured) mean (SD
MT 0.04 (0.07) <0.001 0.06 (0.07)
CT 0.05 (0.07) <0.001 0.09 (0.07)
LT 0.05 (0.07) <0.001 0.08 (0.08)
MF 0.03 (0.09) 0.001 0.08 (0.10)
CF 0.03 (0.10) 0.008 0.09 (0.10)
LF 0.05 (0.15) 0.001 0.10 (0.16)Inﬂuence of activity on BMD
We found a signiﬁcant positive relationship between the Tegner
activity score and the BMD levels at 1- and 2-year follow-up in the
injured knee in all ROIs (beta ranged from 0.018 to 0.024; P value
<0.008; and 0.018 to 0.033; P value <0.008 respectively). At the 2-
years follow-up we also found a signiﬁcant positive relationship
between the Tegner activity score and the contralateral BMD levels
of all tibia regions and the MF region (beta ranged from 0.016 to
0.023; P value <0.008).
Discussion
We found in patients with a recent ACL rupture that operatively
treated patients experienced a decrease in BMD in all ROIs in the
femur and tibia in the ﬁrst year after ACL rupture, followed by an
increase in the second follow-up year. BMD levels in the non-
operatively treated patients were unchanged from baseline at
both follow-ups. For all measurements, the BMD of the injured
knee was lower than that of the contralateral knee in all ROIs, in
both the operatively and non-operatively treated patients.
The ﬁndings of our study are in accordance with the results of
most previous studies19,21. It is well-known that BMD loss is related
to a reduction in either load or physical activity23. After an ACL
injury and after reconstruction there will be a period of reduced
weight bearing and disuse. We can partially clarify the ﬁndings of
the BMD decrease in the ﬁrst year in the injured knee of the
operatively treated patients. Exploratory analysis (not presented)
showed a signiﬁcant negative relationship between delta BMD
levels (baseline e follow-up 1) and the time between reconstruc-
tion and DXA measurement at follow-up 1. Thus, the reduction in
BMD at follow-up 1was not as severe in patients for whom the timepresented in g/cm2 SD; standard deviation. In bold, P values <0.008 (adjusted for
T2
alateral-
)
P value Delta BMD (contralateral-
injured) mean (SD)
P value
<0.001 0.04 (0.07) <0.001
<0.001 0.06 (0.06) <0.001
<0.001 0.05 (0.07) <0.001
<0.001 0.07 (0.09) <0.001
<0.001 0.06 (0.10) <0.001
<0.001 0.07 (0.16) <0.001
Table IV
BMD of injured knees in non-operatively and operatively treated patients. BMD is presented in g/cm2. All analyses were adjusted for age at baseline, BMI and gender. In bold, P
values <0.05. *BMD differences between non-operatively and operatively treated patients in all ROIs and at all time points are not signiﬁcant
ROI* T0
Non-operative n ¼ 47
Operative n ¼ 89
Mean (SD)
T1
Non-operative n ¼ 45
Operative n ¼ 85
Mean (SD)
T2
Non-operative n ¼ 46
Operative n ¼ 82
Mean (SD)
T0eT1
P value
T1eT2
P value
T0eT2
P value
MT non-operative 0.94 (0.14) 0.94 (0.13) 0.94 (0.15) 0.629 0.430 1.000
operative 0.96 (0.12) 0.91 (0.13) 0.96 (0.13) <0.001 <0.001 1.000
CT non-operative 0.93 (0.17) 0.91 (0.17) 0.90 (0.18) 0.006 1.000 0.003
operative 0.97 (0.14) 0.90 (0.13) 0.94 (0.15) <0.001 <0.001 0.002
LT non-operative 0.93 (0.14) 0.92 (0.15) 0.92 (0.15) 0.138 0.950 0.675
operative 0.98 (0.14) 0.90 (0.13) 0.96 (0.15) <0.001 <0.001 0.098
MF non-operative 1.05 (0.14) 1.05 (0.13) 1.03 (0.14) 0.978 1.000 0.299
operative 1.08 (0.11) 1.01 (0.13) 1.03 (0.12) <0.001 0.175 <0.001
CF non-operative 1.34 (0.14) 1.35 (0.17) 1.36 (0.18) 1.000 1.000 0.902
operative 1.37 (0.15) 1.31 (0.15) 1.36 (0.15) <0.001 <0.001 0.931
LF non-operative 1.18 (0.21) 1.18 (0.23) 1.21 (0.22) 1.000 0.086 0.440
operative 1.27 (0.21) 1.19 (0.21) 1.27 (0.23) <0.001 <0.001 1.000
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sumably, these patients were already more active at follow-up 1.
Nine patients were reconstructed after follow-up 1. These patients
also experienced a BMD decrease in the ﬁrst year, but after knee
reconstruction in the second follow-up year, the BMD decreased
further. In these nine patients, the decrease in BMD in the ﬁrst year
could be trauma-related and in the second year reconstruction-
related. In both circumstances, a drop in physical activity is ex-
pected. These ﬁndings suggest that inactivity after trauma and after
reconstruction can inﬂuence BMD. The positive relationship be-
tween the Tegner activity score and BMD levels at the ﬁrst and
second follow-ups in the injured knee supports this explanation.
However, isolated rupture of the medial collateral ligament seemed
to have no long-term effect on BMD, although the immobilization
period after trauma was the same as in patients with an ACL
injury24. This suggests that a period of decreased weight bearing
and disuse after ACL trauma or reconstruction is not the only factor
that inﬂuences BMD. A possible explanation might be that the load
on the injured knee after ACL trauma is changed permanently. This
could also clarify the observed difference in BMD between the
injured and contralateral knees at all time points in all patients in
our study. Unfortunately, we had no information concerning the
loads on the two knees separately.
A key question remains: Is long-term disuse of the injured knee
the only factor that inﬂuences BMD in the knee? It is possible that
other trauma-related factors, such as a direct effect of the trauma,
are involved. First, BMD changes in the operatively treated patients
might be tunnel-related. However, all ROIs located in- and outside
the drilled tunnel had the same pattern regarding BMD changes.
Another possible explanation for the decrease in BMD is the pres-
ence of bone marrow lesions, which are common after an ACL
trauma25,26. Frequently, a characteristic pattern of bone marrow
lesion occurs after an ACL rupture, located in the lateral femur
condyle and the postero-lateral tibia plateau25. Counterarguments
are, ﬁrstly, that bone marrow lesions after an ACL rupture are often
not present in all regions of the tibia and femur, whereas in our
study, the pattern of BMD changes was the same in all ROIs. Sec-
ondly, it has been shown that, 1 year after ACL trauma, the number
and volume of bonemarrow lesions are reduced27,28. Assuming that
the bone marrow lesions were reduced after 1 and 2 years in our
study, the BMD level in the injured knee was still lower than in the
contralateral knee after 1 and 2 years. To our knowledge, no studies
have investigated the relationship between bone marrow lesions
after an ACL rupture and BMD changes in these areas. However, OA-
related bone marrow lesions seem to have a relationship with BMD
changes29,30. A third explanation for the BMD decrease might bethe inﬂuence of local biochemical processes induced after ACL
rupture. These inﬂammation-related factors may affect cartilage
and bone andmay play a role in the initiation of the OA process31,32.
Finally, the difference observed between the operatively and non-
operatively treated patients could be explained by the fact that
reconstruction of the ACL is a second trauma, with new bone
marrow lesions arising due to the drilled tunnel and the release of
inﬂammatory factors.
It is noteworthy that at baseline measurements, 2.6 months
after trauma, already a difference in BMD was present between the
injured and contralateral knees. This may be caused by inactivity
and/or the previously mentioned trauma-related factors.
With the testeretest we demonstrated that our measurements,
positioning of the patient, and placing of the anatomical landmark
points, had good to excellent reproducibility. Additional strengths
of our study are its large sample size and prospective study cohort
design. Most previous studies19,20 which investigated the inﬂuence
of an ACL rupture on the BMD enrolled fewer than 50 patients. To
measure both the direct effect and the unloading effect of ACL
trauma and reconstruction on BMD, wemeasured BMD in the knee:
3 ROIs in the proximal tibia and 3 ROIs in the distal femur. Studies
that measure BMD levels outside the knee can evaluate only the
effect of unloading. In selecting the ROIs, we chose locations in
cancellous bone. This region is more homogeneous in terms of bone
structure than the area just below the articular cartilage, where the
subchondral bone plate causes more variation due to sclerosis33,
which in turn can inﬂuence BMD levels. Additionally, we analyzed
subchondral regions in the tibia (data not presented) and found the
same BMD pattern as for the regions described and used for this
study.
This study had also some limitations. We could not investigate
the previous ﬁndings of a decrease in BMD in the patella19, because
we had no lateral view of the DXA scans. Another limitation is that
our ﬁndings cannot be directly linked to OA, because a longer
follow-up time is necessary.
Future research should investigate the relationship between the
BMD changes that occur after ACL rupture and the development of
degenerative features. Moreover, it is important to know if the BMD
in this population will normalize or increase in the future, because
the ﬁndings in animal and clinical studies suggest a biphasic pro-
cess of BMD changes in OA10e13, 15e18. In a separate study, we found
in a group of 30 non-operatively treated patients that BMD in the
injured knee was lower than in the contralateral knee 5 years after
ACL rupture, but this difference did not reach signiﬁcance (un-
published data). Thus, long-term follow-up of that patient class in
this new prospective cohort is important.
B.L. van Meer et al. / Osteoarthritis and Cartilage 22 (2014) 154e161160In conclusion, the results of this study show that BMD in the
knee decreased after ACL trauma and reconstruction, and after 2
years reached nearly baseline (post-traumatic) levels but remained
lower than the contralateral knee. We could partially explain these
changes in BMD by the physical inactivity that followed the ACL
rupture and reconstruction. The observed BMD differences at all
measurements between injured and contralateral knees might be a
result of differences in load or a direct effect of the trauma on BMD
in the knee.
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